Crystalline Management’s Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 EOCW.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,750
Closed -$1.69K 157
2023
Q1
$1.69K Buy
+18,750
New +$2.17K ﹤0.01% 102

Other funds holding EOCW.WS

Crystalline Management's EOCW.WS Position: Q2 2023 in Review

Crystalline Management sold out of Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (EOCW.WS) in Q2 2023, closing a stake of 18,750 shares — an estimated $1.69K sold.

Crystalline Management first reported a position in EOCW.WS in Q1 2023 and held it in 1 quarter. The position peaked at $1.69K in Q1 2023. 9 funds tracked by Wall St. Rank hold EOCW.WS as of Q2 2023.

  • Crystalline Management reported no remaining Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • Crystalline Management sold 18,750 Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2023, an estimated $1.69K.
  • Crystalline Management first reported a position in Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2023 and held it in 1 quarter.
  • Crystalline Management's Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $1.69K in Q1 2023.
  • 9 funds tracked by Wall St. Rank held Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2023.

Based on Crystalline Management's 13F filing for Q2 2023, filed 9 Aug 2023.